第四季度，菲利普的可比訂單量增長了2%，其中北美和增長市場表現強勁，但部分被中國市場需求的兩位數下降所抵消。集團的可比銷售額在本季度增長了1%，而除中國外的其他地區實現了5%的穩健增長，但被中國市場兩位數的下降基本抵消。市場狀況預期在中國仍然不確定。調整後EBITA在第四季度提升了60個基點，達到13.5%，這得益於運營改進和生產力措施。自由現金流在該季度增長至13億歐元，這主要得益於Respironics保險收益，部分被營運資本的階段性變化所抵消。

以上內容來自Benzinga Earnings專欄，原文如下：

Comparable order intake increased 2% in the quarter, with strong performance in the North America and Growth geographies, partly offset by a double-digit decline in demand in China. Group comparable sales increased 1% in the quarter, with solid growth of 5% in the rest of the world, largely offset by a double-digit decline in China, where market conditions are expected to remain uncertain. 

Adjusted EBITA increased 60 basis points to 13.5% in Q4, driven by operational improvements and productivity measures. Free cash flow increased to EUR 1.3 billion in the quarter, driven by Respironics insurance proceeds, partly offset by phasing in working capital